Gabriella Fanali
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Gabriella Fanali has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Mauro Fasano
Department of Science and High Technology, University of Insubria, 22100 Como, Italy
3 shared publications Paolo Ascenzi
Interdepartmental Laboratory for Electron Microscopy, University Roma Tre, Roma, Italy
2 shared publications- Alessandro Bolli
Department of Biology, University Roma Tre, Roma, Italy
1 shared publication Angelo Azzi
Vascular Biology Laboratory, Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston, MA, USA
1 shared publicationDaniela Parolaro
Department of Structural and Functional Biology, and Center of Neuroscience, University of Insubria, Via Alberto da Giussano 12, Busto Arsizio (VA), Italy
1 shared publicationFrancesca Gullotta
1 shared publication
Latest Publications
- 28 January 2013
- Published by Wiley in BioFactors
- Vol. 39 (3) , 294-303
α‐Tocopherol binding to human serum albumin
Given the ability of human serum albumin (HSA) to bind hydrophobic ligands, the binding mode of α‐tocopherol, the most representative member of the vitamin E family, is reported. α‐Tocopherol binds to HSA withK$_{\rm d}^0$ = (7.0 ± 3.0) × 10−6M (pH 7.2, 25.0°C). Competitive and allosteric modulation of α‐tocopherol binding to full‐length and truncated (Asp1‐Glu382) HSA by endogenous and exogenous ligands suggests that it accommodates preferentially in the FA3–FA4 site. As HSA is taken up into cells, colocalizes with the α‐tocopherol transfer protein, and contributes to ligand secretion via ABCA1, it might participate in the distribution of α‐tocopherol between plasma, cells, and tissues. © 2013 BioFactors, 2013
- 28 January 2013
- Published by Wiley in BioFactors
- Vol. 39 (3) , 294-303
α‐Tocopherol binding to human serum albumin
Given the ability of human serum albumin (HSA) to bind hydrophobic ligands, the binding mode of α‐tocopherol, the most representative member of the vitamin E family, is reported. α‐Tocopherol binds to HSA withK$_{\rm d}^0$ = (7.0 ± 3.0) × 10−6M (pH 7.2, 25.0°C). Competitive and allosteric modulation of α‐tocopherol binding to full‐length and truncated (Asp1‐Glu382) HSA by endogenous and exogenous ligands suggests that it accommodates preferentially in the FA3–FA4 site. As HSA is taken up into cells, colocalizes with the α‐tocopherol transfer protein, and contributes to ligand secretion via ABCA1, it might participate in the distribution of α‐tocopherol between plasma, cells, and tissues. © 2013 BioFactors, 2013
- Open Access
- 20 December 2011
- Published by Wiley in IUBMB Life
- Vol. 63 (12) , 1116
Drug binding to sudlow's site i impairs allosterically human serum heme-albumin-catalyzed peroxynitrite detoxification, iubmb life 2010 oct;62(10):776-80
- 20 December 2011
- Published by Wiley in IUBMB Life
- Vol. 63 (12) , 1116
Open AccessDrug binding to sudlow's site i impairs allosterically human serum heme-albumin-catalyzed peroxynitrite detoxification, iubmb life 2010 oct;62(10):776-80
- Open Access
- 9 May 2011
- Published by Wiley in IUBMB Life
- Vol. 63 (6) , 446-451
Binding of δ9‐tetrahydrocannabinol and diazepam to human serum albumin
Cannabis is the most commonly used illicit drug worldwide. Cannabis users also appear to use other psychoactive drugs more frequently than noncannabis users. Here, Δ9‐ tetrahydrocannabinol (THC) and diazepam binding to human serum albumin (HSA) and HSA‐heme is reported. THC binds to two different binding sites of HSA (Kd1≤ 10−7M andKd2= 10−3M) without affecting diazepam binding (Kd= 1.2 × 10−5M). THC binding to the high‐affinity site accounts for the low free fraction of the drug in plasma. Moreover, THC increases the affinity of heme for HSA. Accordingly, the affinity of THC for HSA‐heme is higher than that for HSA. THC could bind to FA2 and FA7 sites, as substantiated by docking simulations; nevertheless, the observed allosteric effect(s) suggests that the primary binding site of THC is the FA2 cleft that positively modulates heme affinity. Possibly, the HSA conformational transition(s) induced by THC binding could account for drug delivery to the liver through receptor‐ mediated endocytosis. © 2011 IUBMB IUBMB Life, 63(6): 446–451, 2011
- 9 May 2011
- Published by Wiley in IUBMB Life
- Vol. 63 (6) , 446-451
Open AccessBinding of δ9‐tetrahydrocannabinol and diazepam to human serum albumin
Cannabis is the most commonly used illicit drug worldwide. Cannabis users also appear to use other psychoactive drugs more frequently than noncannabis users. Here, Δ9‐ tetrahydrocannabinol (THC) and diazepam binding to human serum albumin (HSA) and HSA‐heme is reported. THC binds to two different binding sites of HSA (Kd1≤ 10−7M andKd2= 10−3M) without affecting diazepam binding (Kd= 1.2 × 10−5M). THC binding to the high‐affinity site accounts for the low free fraction of the drug in plasma. Moreover, THC increases the affinity of heme for HSA. Accordingly, the affinity of THC for HSA‐heme is higher than that for HSA. THC could bind to FA2 and FA7 sites, as substantiated by docking simulations; nevertheless, the observed allosteric effect(s) suggests that the primary binding site of THC is the FA2 cleft that positively modulates heme affinity. Possibly, the HSA conformational transition(s) induced by THC binding could account for drug delivery to the liver through receptor‐ mediated endocytosis. © 2011 IUBMB IUBMB Life, 63(6): 446–451, 2011